Cisen Pharmaceutical Hits Day Low of CNY 14.01 Amid Price Pressure

Cisen Pharmaceutical has experienced a notable decline today, with the stock dropping by 5.43% and reaching an intraday low of CNY 14.01. This performance contrasts with the China Shanghai Composite, which saw a slight increase of 0.04% on the same day. Over the past week, Cisen's stock has decreased by 6.87%, while the broader market index fell by 0.56%. In terms of longer-term performance, Cisen Pharmaceutical has faced significant challenges, with a year-to-date decline of 18.59% and a staggering 53% drop over the past year. The company's net sales for the first nine months have decreased by 12.88%, and it has reported negative results for three consecutive quarters. Key financial metrics indicate a low inventory turnover ratio of 2.15 times and an operating profit of CNY 85.93 million, both of which are at their lowest levels. Despite these challenges, Cisen maintains a return on equity of 7.41% and a price-to-book ratio of 1.48, suggesting a valuation that may attract attention. The company also offers a dividend yield of 2.32%, which could be appealing in the current market environment.